What is Microbot Medical's restricted cash?

Microbot Medical (MBOT) reported restricted cash of $200K in Q1 2026.

How has Microbot Medical's restricted cash changed year-over-year?

Microbot Medical's restricted cash increased by 316.7% year-over-year, from $48K to $200K.

What is the long-term trend for Microbot Medical's restricted cash?

Over 5 years (2020 to 2025), Microbot Medical's restricted cash has grown at a -52.6% compound annual growth rate (CAGR), from $84K to $2K.

What does restricted cash mean?

Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.

Microbot Medical MBOT Restricted Cash

Restricted Cash at other companies

StereotaxisSTXS

$6.97M+1,348%

PROCEPT BioRobotics CorporationPRCT

$3.04M0.0%

Intuitive SurgicalISRG

——

Boston ScientificBSX

——

Other financials

Income statement

See full

Revenue$105.0K—

Gross profit$2.0K—

Operating income-$4.3M-43.0%

Net income-$3.7M-41.1%

EPS (diluted)-$0.05+37.5%

Balance sheet

See full

Cash & equivalents$3.7M+13.7%

Total debt$898.0K+551%

Total equity$74.1M+156%

Total assets$78.1M+153%

Cash flow

See full

Operating cash flow-$5.1M-75.8%

CapEx$108.0K+731%

Free cash flow-$5.2M-78.8%

Valuation

See full

Market cap$128.28M+36.1%

Enterprise value$125.53M+39.0%

P/S674.3×—

Profitability

See full

Operating margin25,292.9%—

Net margin-3,669.9%—

FCF margin-852.8%—

Returns & leverage

See full

Return on equity-27.6%-10.2pp

Debt / equity0×0.0×

Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue.

The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Microbot Medical's restricted cash?: Microbot Medical (MBOT) reported restricted cash of $200K in Q1 2026.
How has Microbot Medical's restricted cash changed year-over-year?: Microbot Medical's restricted cash increased by 316.7% year-over-year, from $48K to $200K.
What is the long-term trend for Microbot Medical's restricted cash?: Over 5 years (2020 to 2025), Microbot Medical's restricted cash has grown at a -52.6% compound annual growth rate (CAGR), from $84K to $2K.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.